Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Revenue

Medexus Pharmaceuticals had revenue of $24.62M USD in the quarter ending June 30, 2025, a decrease of -9.78%. This brings the company's revenue in the last twelve months to $105.66M, down -2.87% year-over-year. In the fiscal year ending March 31, 2025, Medexus Pharmaceuticals had annual revenue of $108.33M, down -4.18%.

• Revenue (ttm): $105.66M
• Revenue Growth: -2.87%
• P/S Ratio: 0.68
• Revenue / Employee: $1.16M
• Employees: 91
• Market Cap: 98.54M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	108.33M	-4.72M	-4.18%
Mar 31, 2024	113.05M	4.96M	4.59%
Mar 31, 2023	108.10M	31.40M	40.93%
Mar 31, 2022	76.70M	-2.96M	-3.71%
Mar 31, 2021	79.66M	24.15M	43.52%